Furumoto S - Search Results

1

Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease.

Li Y, Tsui W, Rusinek H, Butler T, Mosconi L, Pirraglia E, Mozley D, Vallabhajosula S, Harada R, Furumoto S, Furukawa K, Arai H, Kudo Y, Okamura N, de Leon MJ. Li Y, et al. Among authors: furumoto s. J Nucl Med. 2015 Feb;56(2):270-3. doi: 10.2967/jnumed.114.149229. Epub 2015 Jan 8. J Nucl Med. 2015. PMID: 25572087 Free PMC article.

2

[Development of [18F]FRP-170 injection for imaging hypoxia by PET].

Ishikawa Y, Funaki Y, Iwata R, Furumoto S, Nakata E, Kudo Y, Kaneta T, Hakamatsuka T, Takai Y, Yamada S. Ishikawa Y, et al. Among authors: furumoto s. Kaku Igaku. 2005 Feb;42(1):1-10. Kaku Igaku. 2005. PMID: 15794116 Japanese.

3

Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease.

Okamura N, Suemoto T, Furumoto S, Suzuki M, Shimadzu H, Akatsu H, Yamamoto T, Fujiwara H, Nemoto M, Maruyama M, Arai H, Yanai K, Sawada T, Kudo Y. Okamura N, et al. Among authors: furumoto s. J Neurosci. 2005 Nov 23;25(47):10857-62. doi: 10.1523/JNEUROSCI.1738-05.2005. J Neurosci. 2005. PMID: 16306398 Free PMC article.

4

[Alzheimer' s disease].

Okamura N, Furumoto S, Kudo Y, Yanai K. Okamura N, et al. Among authors: furumoto s. Nihon Rinsho. 2007 Feb;65(2):320-6. Nihon Rinsho. 2007. PMID: 17302278 Review. Japanese.

5

2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.

Kudo Y, Okamura N, Furumoto S, Tashiro M, Furukawa K, Maruyama M, Itoh M, Iwata R, Yanai K, Arai H. Kudo Y, et al. Among authors: furumoto s. J Nucl Med. 2007 Apr;48(4):553-61. doi: 10.2967/jnumed.106.037556. J Nucl Med. 2007. PMID: 17401091 Free article.

6

Recent advances in the development of amyloid imaging agents.

Furumoto S, Okamura N, Iwata R, Yanai K, Arai H, Kudo Y. Furumoto S, et al. Curr Top Med Chem. 2007;7(18):1773-89. doi: 10.2174/156802607782507402. Curr Top Med Chem. 2007. PMID: 17979786

7

Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease.

Waragai M, Okamura N, Furukawa K, Tashiro M, Furumoto S, Funaki Y, Kato M, Iwata R, Yanai K, Kudo Y, Arai H. Waragai M, et al. Among authors: furumoto s. J Neurol Sci. 2009 Oct 15;285(1-2):100-8. doi: 10.1016/j.jns.2009.06.005. Epub 2009 Jun 23. J Neurol Sci. 2009. PMID: 19552926

8

In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.

Fodero-Tavoletti MT, Mulligan RS, Okamura N, Furumoto S, Rowe CC, Kudo Y, Masters CL, Cappai R, Yanai K, Villemagne VL. Fodero-Tavoletti MT, et al. Among authors: furumoto s. Eur J Pharmacol. 2009 Sep 1;617(1-3):54-8. doi: 10.1016/j.ejphar.2009.06.042. Epub 2009 Jul 1. Eur J Pharmacol. 2009. PMID: 19576880

9

Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.

Furukawa K, Okamura N, Tashiro M, Waragai M, Furumoto S, Iwata R, Yanai K, Kudo Y, Arai H. Furukawa K, et al. Among authors: furumoto s. J Neurol. 2010 May;257(5):721-7. doi: 10.1007/s00415-009-5396-8. Epub 2009 Nov 28. J Neurol. 2010. PMID: 19946781

10

In vivo detection of prion amyloid plaques using [(11)C]BF-227 PET.

Okamura N, Shiga Y, Furumoto S, Tashiro M, Tsuboi Y, Furukawa K, Yanai K, Iwata R, Arai H, Kudo Y, Itoyama Y, Doh-ura K. Okamura N, et al. Among authors: furumoto s. Eur J Nucl Med Mol Imaging. 2010 May;37(5):934-41. doi: 10.1007/s00259-009-1314-7. Epub 2009 Dec 17. Eur J Nucl Med Mol Imaging. 2010. PMID: 20016895 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters